The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Hemostatic Forceps Market Outlook 2024

Global Hemostatic Forceps Market Outlook 2024

Publishing Date : Jan, 2022

License Type :
 

Report Code : 1662558

No of Pages : 137

Synopsis
Hemostatic Forceps (also called a Hemostat) is a surgical tool used in many surgical procedures to control bleeding or the flow of liquids in tubing. They have ring handles just like scissors. The ratcheted handles can be locked in multiple positions in order to maintain variable levels of constant pressure.
For different application, there are generally three types of hemostatic forceps, which include Halstead mosquito hemostatic forceps, Kelly and Crile hemostatic forceps and Rochester-Carmalt hemostatic forceps.
Global Hemostatic Forceps key players include Medline, B. Braun, CareFusion, Sklar, Scanlan International, etc. Global top five manufacturers hold a share over 45%.
North America is the largest market, with a share over 30%, followed by Europe and China, both have a share about 45%.
In terms of product, Halstead Mosquito Hemostatic Forceps is the largest segment, with a share over 55%.

The global Hemostatic Forceps market was valued at US$ 57 million in 2020 and is expected to reach US$ 77 million by the end of 2027, growing at a CAGR of 4.3% during 2021-2027.
This report focuses on Hemostatic Forceps volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Hemostatic Forceps market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Hemostatic Forceps Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Halstead Mosquito Hemostatic Forceps
Kelly and Crile Hemostatic Forceps
Rochester-Carmalt Hemostatic Forceps

Segment by Application
Surgical
Dissection
Dental
Laparoscopic
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Medline
B. Braun
CareFusion
Asa Dental
Sklar
Scanlan International
Shanghai Medical Instruments
Lawton
Hu-Friedy
Xinhua Surgical
Towne Brothers
Teleflex Medical
Delacroix Chevalier
YDM
M A Corporation
MedGyn Products
Inami
Ted Pella
Medicon eG
J & J Instruments
American Diagnostic
Index
1 Hemostatic Forceps Market Overview
1.1 Product Overview and Scope of Hemostatic Forceps
1.2 Hemostatic Forceps Segment by Type
1.2.1 Global Hemostatic Forceps Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Halstead Mosquito Hemostatic Forceps
1.2.3 Kelly and Crile Hemostatic Forceps
1.2.4 Rochester-Carmalt Hemostatic Forceps
1.3 Hemostatic Forceps Segment by Application
1.3.1 Global Hemostatic Forceps Sales Comparison by Application: (2021-2027)
1.3.2 Surgical
1.3.3 Dissection
1.3.4 Dental
1.3.5 Laparoscopic
1.3.6 Others
1.4 Global Hemostatic Forceps Market Size Estimates and Forecasts
1.4.1 Global Hemostatic Forceps Revenue 2016-2027
1.4.2 Global Hemostatic Forceps Sales 2016-2027
1.4.3 Hemostatic Forceps Market Size by Region: 2016 Versus 2021 Versus 2027

2 Hemostatic Forceps Market Competition by Manufacturers
2.1 Global Hemostatic Forceps Sales Market Share by Manufacturers (2016-2021)
2.2 Global Hemostatic Forceps Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Hemostatic Forceps Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Hemostatic Forceps Manufacturing Sites, Area Served, Product Type
2.5 Hemostatic Forceps Market Competitive Situation and Trends
2.5.1 Hemostatic Forceps Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Hemostatic Forceps Players Market Share by Revenue
2.5.3 Global Hemostatic Forceps Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hemostatic Forceps Retrospective Market Scenario by Region
3.1 Global Hemostatic Forceps Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Hemostatic Forceps Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Hemostatic Forceps Market Facts & Figures by Country
3.3.1 North America Hemostatic Forceps Sales by Country
3.3.2 North America Hemostatic Forceps Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Hemostatic Forceps Market Facts & Figures by Country
3.4.1 Europe Hemostatic Forceps Sales by Country
3.4.2 Europe Hemostatic Forceps Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Hemostatic Forceps Market Facts & Figures by Region
3.5.1 Asia Pacific Hemostatic Forceps Sales by Region
3.5.2 Asia Pacific Hemostatic Forceps Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Hemostatic Forceps Market Facts & Figures by Country
3.6.1 Latin America Hemostatic Forceps Sales by Country
3.6.2 Latin America Hemostatic Forceps Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Hemostatic Forceps Market Facts & Figures by Country
3.7.1 Middle East and Africa Hemostatic Forceps Sales by Country
3.7.2 Middle East and Africa Hemostatic Forceps Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Hemostatic Forceps Historic Market Analysis by Type
4.1 Global Hemostatic Forceps Sales Market Share by Type (2016-2021)
4.2 Global Hemostatic Forceps Revenue Market Share by Type (2016-2021)
4.3 Global Hemostatic Forceps Price by Type (2016-2021)

5 Global Hemostatic Forceps Historic Market Analysis by Application
5.1 Global Hemostatic Forceps Sales Market Share by Application (2016-2021)
5.2 Global Hemostatic Forceps Revenue Market Share by Application (2016-2021)
5.3 Global Hemostatic Forceps Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Medline
6.1.1 Medline Corporation Information
6.1.2 Medline Description and Business Overview
6.1.3 Medline Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Medline Hemostatic Forceps Product Portfolio
6.1.5 Medline Recent Developments/Updates
6.2 B. Braun
6.2.1 B. Braun Corporation Information
6.2.2 B. Braun Description and Business Overview
6.2.3 B. Braun Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.2.4 B. Braun Hemostatic Forceps Product Portfolio
6.2.5 B. Braun Recent Developments/Updates
6.3 CareFusion
6.3.1 CareFusion Corporation Information
6.3.2 CareFusion Description and Business Overview
6.3.3 CareFusion Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.3.4 CareFusion Hemostatic Forceps Product Portfolio
6.3.5 CareFusion Recent Developments/Updates
6.4 Asa Dental
6.4.1 Asa Dental Corporation Information
6.4.2 Asa Dental Description and Business Overview
6.4.3 Asa Dental Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Asa Dental Hemostatic Forceps Product Portfolio
6.4.5 Asa Dental Recent Developments/Updates
6.5 Sklar
6.5.1 Sklar Corporation Information
6.5.2 Sklar Description and Business Overview
6.5.3 Sklar Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Sklar Hemostatic Forceps Product Portfolio
6.5.5 Sklar Recent Developments/Updates
6.6 Scanlan International
6.6.1 Scanlan International Corporation Information
6.6.2 Scanlan International Description and Business Overview
6.6.3 Scanlan International Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Scanlan International Hemostatic Forceps Product Portfolio
6.6.5 Scanlan International Recent Developments/Updates
6.7 Shanghai Medical Instruments
6.6.1 Shanghai Medical Instruments Corporation Information
6.6.2 Shanghai Medical Instruments Description and Business Overview
6.6.3 Shanghai Medical Instruments Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Shanghai Medical Instruments Hemostatic Forceps Product Portfolio
6.7.5 Shanghai Medical Instruments Recent Developments/Updates
6.8 Lawton
6.8.1 Lawton Corporation Information
6.8.2 Lawton Description and Business Overview
6.8.3 Lawton Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Lawton Hemostatic Forceps Product Portfolio
6.8.5 Lawton Recent Developments/Updates
6.9 Hu-Friedy
6.9.1 Hu-Friedy Corporation Information
6.9.2 Hu-Friedy Description and Business Overview
6.9.3 Hu-Friedy Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Hu-Friedy Hemostatic Forceps Product Portfolio
6.9.5 Hu-Friedy Recent Developments/Updates
6.10 Xinhua Surgical
6.10.1 Xinhua Surgical Corporation Information
6.10.2 Xinhua Surgical Description and Business Overview
6.10.3 Xinhua Surgical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Xinhua Surgical Hemostatic Forceps Product Portfolio
6.10.5 Xinhua Surgical Recent Developments/Updates
6.11 Towne Brothers
6.11.1 Towne Brothers Corporation Information
6.11.2 Towne Brothers Hemostatic Forceps Description and Business Overview
6.11.3 Towne Brothers Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Towne Brothers Hemostatic Forceps Product Portfolio
6.11.5 Towne Brothers Recent Developments/Updates
6.12 Teleflex Medical
6.12.1 Teleflex Medical Corporation Information
6.12.2 Teleflex Medical Hemostatic Forceps Description and Business Overview
6.12.3 Teleflex Medical Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Teleflex Medical Hemostatic Forceps Product Portfolio
6.12.5 Teleflex Medical Recent Developments/Updates
6.13 Delacroix Chevalier
6.13.1 Delacroix Chevalier Corporation Information
6.13.2 Delacroix Chevalier Hemostatic Forceps Description and Business Overview
6.13.3 Delacroix Chevalier Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Delacroix Chevalier Hemostatic Forceps Product Portfolio
6.13.5 Delacroix Chevalier Recent Developments/Updates
6.14 YDM
6.14.1 YDM Corporation Information
6.14.2 YDM Hemostatic Forceps Description and Business Overview
6.14.3 YDM Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.14.4 YDM Hemostatic Forceps Product Portfolio
6.14.5 YDM Recent Developments/Updates
6.15 M A Corporation
6.15.1 M A Corporation Corporation Information
6.15.2 M A Corporation Hemostatic Forceps Description and Business Overview
6.15.3 M A Corporation Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.15.4 M A Corporation Hemostatic Forceps Product Portfolio
6.15.5 M A Corporation Recent Developments/Updates
6.16 MedGyn Products
6.16.1 MedGyn Products Corporation Information
6.16.2 MedGyn Products Hemostatic Forceps Description and Business Overview
6.16.3 MedGyn Products Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.16.4 MedGyn Products Hemostatic Forceps Product Portfolio
6.16.5 MedGyn Products Recent Developments/Updates
6.17 Inami
6.17.1 Inami Corporation Information
6.17.2 Inami Hemostatic Forceps Description and Business Overview
6.17.3 Inami Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Inami Hemostatic Forceps Product Portfolio
6.17.5 Inami Recent Developments/Updates
6.18 Ted Pella
6.18.1 Ted Pella Corporation Information
6.18.2 Ted Pella Hemostatic Forceps Description and Business Overview
6.18.3 Ted Pella Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Ted Pella Hemostatic Forceps Product Portfolio
6.18.5 Ted Pella Recent Developments/Updates
6.19 Medicon eG
6.19.1 Medicon eG Corporation Information
6.19.2 Medicon eG Hemostatic Forceps Description and Business Overview
6.19.3 Medicon eG Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Medicon eG Hemostatic Forceps Product Portfolio
6.19.5 Medicon eG Recent Developments/Updates
6.20 J & J Instruments
6.20.1 J & J Instruments Corporation Information
6.20.2 J & J Instruments Hemostatic Forceps Description and Business Overview
6.20.3 J & J Instruments Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.20.4 J & J Instruments Hemostatic Forceps Product Portfolio
6.20.5 J & J Instruments Recent Developments/Updates
6.21 American Diagnostic
6.21.1 American Diagnostic Corporation Information
6.21.2 American Diagnostic Hemostatic Forceps Description and Business Overview
6.21.3 American Diagnostic Hemostatic Forceps Sales, Revenue and Gross Margin (2016-2021)
6.21.4 American Diagnostic Hemostatic Forceps Product Portfolio
6.21.5 American Diagnostic Recent Developments/Updates

7 Hemostatic Forceps Manufacturing Cost Analysis
7.1 Hemostatic Forceps Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Hemostatic Forceps
7.4 Hemostatic Forceps Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Hemostatic Forceps Distributors List
8.3 Hemostatic Forceps Customers

9 Hemostatic Forceps Market Dynamics
9.1 Hemostatic Forceps Industry Trends
9.2 Hemostatic Forceps Growth Drivers
9.3 Hemostatic Forceps Market Challenges
9.4 Hemostatic Forceps Market Restraints

10 Global Market Forecast
10.1 Hemostatic Forceps Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Hemostatic Forceps by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Hemostatic Forceps by Type (2022-2027)
10.2 Hemostatic Forceps Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Hemostatic Forceps by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Hemostatic Forceps by Application (2022-2027)
10.3 Hemostatic Forceps Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Hemostatic Forceps by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Hemostatic Forceps by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Hemostatic Forceps Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Hemostatic Forceps Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Hemostatic Forceps Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Hemostatic Forceps Covered in This Study
Table 5. Global Hemostatic Forceps Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Hemostatic Forceps Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Hemostatic Forceps Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Hemostatic Forceps Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Hemostatic Forceps Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Hemostatic Forceps Manufacturing Sites and Area Served
Table 11. Manufacturers Hemostatic Forceps Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Hemostatic Forceps by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostatic Forceps as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Hemostatic Forceps Sales by Region (2016-2021) & (K Units)
Table 16. Global Hemostatic Forceps Sales Market Share by Region (2016-2021)
Table 17. Global Hemostatic Forceps Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Hemostatic Forceps Sales by Country (2016-2021) & (K Units)
Table 19. North America Hemostatic Forceps Sales Market Share by Country (2016-2021)
Table 20. North America Hemostatic Forceps Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Hemostatic Forceps Revenue Market Share by Country (2016-2021)
Table 22. Europe Hemostatic Forceps Sales by Country (2016-2021) & (K Units)
Table 23. Europe Hemostatic Forceps Sales Market Share by Country (2016-2021)
Table 24. Europe Hemostatic Forceps Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Hemostatic Forceps Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Hemostatic Forceps Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Hemostatic Forceps Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Hemostatic Forceps Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Hemostatic Forceps Revenue Market Share by Region (2016-2021)
Table 30. Latin America Hemostatic Forceps Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Hemostatic Forceps Sales Market Share by Country (2016-2021)
Table 32. Latin America Hemostatic Forceps Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Hemostatic Forceps Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Hemostatic Forceps Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Hemostatic Forceps Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Hemostatic Forceps Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Hemostatic Forceps Revenue Market Share by Country (2016-2021)
Table 38. Global Hemostatic Forceps Sales (K Units) by Type (2016-2021)
Table 39. Global Hemostatic Forceps Sales Market Share by Type (2016-2021)
Table 40. Global Hemostatic Forceps Revenue (Million US$) by Type (2016-2021)
Table 41. Global Hemostatic Forceps Revenue Share by Type (2016-2021)
Table 42. Global Hemostatic Forceps Price (USD/Unit) by Type (2016-2021)
Table 43. Global Hemostatic Forceps Sales (K Units) by Application (2016-2021)
Table 44. Global Hemostatic Forceps Sales Market Share by Application (2016-2021)
Table 45. Global Hemostatic Forceps Revenue (Million US$) by Application (2016-2021)
Table 46. Global Hemostatic Forceps Revenue Share by Application (2016-2021)
Table 47. Global Hemostatic Forceps Price (USD/Unit) by Application (2016-2021)
Table 48. Medline Corporation Information
Table 49. Medline Description and Business Overview
Table 50. Medline Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Medline Hemostatic Forceps Product
Table 52. Medline Recent Developments/Updates
Table 53. B. Braun Corporation Information
Table 54. B. Braun Description and Business Overview
Table 55. B. Braun Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. B. Braun Hemostatic Forceps Product
Table 57. B. Braun Recent Developments/Updates
Table 58. CareFusion Corporation Information
Table 59. CareFusion Description and Business Overview
Table 60. CareFusion Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. CareFusion Hemostatic Forceps Product
Table 62. CareFusion Recent Developments/Updates
Table 63. Asa Dental Corporation Information
Table 64. Asa Dental Description and Business Overview
Table 65. Asa Dental Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Asa Dental Hemostatic Forceps Product
Table 67. Asa Dental Recent Developments/Updates
Table 68. Sklar Corporation Information
Table 69. Sklar Description and Business Overview
Table 70. Sklar Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Sklar Hemostatic Forceps Product
Table 72. Sklar Recent Developments/Updates
Table 73. Scanlan International Corporation Information
Table 74. Scanlan International Description and Business Overview
Table 75. Scanlan International Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Scanlan International Hemostatic Forceps Product
Table 77. Scanlan International Recent Developments/Updates
Table 78. Shanghai Medical Instruments Corporation Information
Table 79. Shanghai Medical Instruments Description and Business Overview
Table 80. Shanghai Medical Instruments Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Shanghai Medical Instruments Hemostatic Forceps Product
Table 82. Shanghai Medical Instruments Recent Developments/Updates
Table 83. Lawton Corporation Information
Table 84. Lawton Description and Business Overview
Table 85. Lawton Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 86. Lawton Hemostatic Forceps Product
Table 87. Lawton Recent Developments/Updates
Table 88. Hu-Friedy Corporation Information
Table 89. Hu-Friedy Description and Business Overview
Table 90. Hu-Friedy Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 91. Hu-Friedy Hemostatic Forceps Product
Table 92. Hu-Friedy Recent Developments/Updates
Table 93. Xinhua Surgical Corporation Information
Table 94. Xinhua Surgical Description and Business Overview
Table 95. Xinhua Surgical Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 96. Xinhua Surgical Hemostatic Forceps Product
Table 97. Xinhua Surgical Recent Developments/Updates
Table 98. Towne Brothers Corporation Information
Table 99. Towne Brothers Description and Business Overview
Table 100. Towne Brothers Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 101. Towne Brothers Hemostatic Forceps Product
Table 102. Towne Brothers Recent Developments/Updates
Table 103. Teleflex Medical Corporation Information
Table 104. Teleflex Medical Description and Business Overview
Table 105. Teleflex Medical Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 106. Teleflex Medical Hemostatic Forceps Product
Table 107. Teleflex Medical Recent Developments/Updates
Table 108. Delacroix Chevalier Corporation Information
Table 109. Delacroix Chevalier Description and Business Overview
Table 110. Delacroix Chevalier Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Delacroix Chevalier Hemostatic Forceps Product
Table 112. Delacroix Chevalier Recent Developments/Updates
Table 113. YDM Corporation Information
Table 114. YDM Description and Business Overview
Table 115. YDM Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. YDM Hemostatic Forceps Product
Table 117. YDM Recent Developments/Updates
Table 118. M A Corporation Corporation Information
Table 119. M A Corporation Description and Business Overview
Table 120. M A Corporation Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. M A Corporation Hemostatic Forceps Product
Table 122. M A Corporation Recent Developments/Updates
Table 123. MedGyn Products Corporation Information
Table 124. MedGyn Products Description and Business Overview
Table 125. MedGyn Products Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. MedGyn Products Hemostatic Forceps Product
Table 127. MedGyn Products Recent Developments/Updates
Table 128. Inami Corporation Information
Table 129. Inami Description and Business Overview
Table 130. Inami Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Inami Hemostatic Forceps Product
Table 132. Inami Recent Developments/Updates
Table 133. Ted Pella Corporation Information
Table 134. Ted Pella Description and Business Overview
Table 135. Ted Pella Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Ted Pella Hemostatic Forceps Product
Table 137. Ted Pella Recent Developments/Updates
Table 138. Medicon eG Corporation Information
Table 139. Medicon eG Description and Business Overview
Table 140. Medicon eG Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Medicon eG Hemostatic Forceps Product
Table 142. Medicon eG Recent Developments/Updates
Table 143. J & J Instruments Corporation Information
Table 144. J & J Instruments Description and Business Overview
Table 145. J & J Instruments Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. J & J Instruments Hemostatic Forceps Product
Table 147. J & J Instruments Recent Developments/Updates
Table 148. American Diagnostic Corporation Information
Table 149. American Diagnostic Description and Business Overview
Table 150. American Diagnostic Hemostatic Forceps Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. American Diagnostic Hemostatic Forceps Product
Table 152. American Diagnostic Recent Developments/Updates
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Hemostatic Forceps Distributors List
Table 156. Hemostatic Forceps Customers List
Table 157. Hemostatic Forceps Market Trends
Table 158. Hemostatic Forceps Growth Drivers
Table 159. Hemostatic Forceps Market Challenges
Table 160. Hemostatic Forceps Market Restraints
Table 161. Global Hemostatic Forceps Sales Forecast by Type (2022-2027) & (K Units)
Table 162. Global Hemostatic Forceps Sales Market Share Forecast by Type (2022-2027)
Table 163. Global Hemostatic Forceps Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 164. Global Hemostatic Forceps Revenue Market Share Forecast by Type (2022-2027)
Table 165. Global Hemostatic Forceps Sales Forecast by Application (2022-2027) & (K Units)
Table 166. Global Hemostatic Forceps Sales Market Share Forecast by Application (2022-2027)
Table 167. Global Hemostatic Forceps Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 168. Global Hemostatic Forceps Revenue Market Share Forecast by Application (2022-2027)
Table 169. Global Hemostatic Forceps Sales Forecast by Region (2022-2027) & (K Units)
Table 170. Global Hemostatic Forceps Sales Market Share Forecast by Region (2022-2027)
Table 171. Global Hemostatic Forceps Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 172. Global Hemostatic Forceps Revenue Market Share Forecast by Region (2022-2027)
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hemostatic Forceps
Figure 2. Global Hemostatic Forceps Market Share by Type in 2020 & 2027
Figure 3. Halstead Mosquito Hemostatic Forceps Product Picture
Figure 4. Kelly and Crile Hemostatic Forceps Product Picture
Figure 5. Rochester-Carmalt Hemostatic Forceps Product Picture
Figure 6. Global Hemostatic Forceps Market Share by Application in 2020 & 2027
Figure 7. Surgical
Figure 8. Dissection
Figure 9. Dental
Figure 10. Laparoscopic
Figure 11. Others
Figure 12. Global Hemostatic Forceps Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Hemostatic Forceps Market Size 2016-2027 (US$ Million)
Figure 14. Global Hemostatic Forceps Sales 2016-2027 (K Units)
Figure 15. Global Hemostatic Forceps Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 16. Hemostatic Forceps Sales Share by Manufacturers in 2020
Figure 17. Global Hemostatic Forceps Revenue Share by Manufacturers in 2020
Figure 18. The Global 5 and 10 Largest Hemostatic Forceps Players: Market Share by Revenue in 2020
Figure 19. Hemostatic Forceps Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 20. Global Hemostatic Forceps Sales Market Share by Region (2016-2021)
Figure 21. Global Hemostatic Forceps Sales Market Share by Region in 2020
Figure 22. Global Hemostatic Forceps Revenue Market Share by Region (2016-2021)
Figure 23. Global Hemostatic Forceps Revenue Market Share by Region in 2020
Figure 24. U.S. Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Canada Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Germany Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. France Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. U.K. Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Italy Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Russia Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. China Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Japan Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. South Korea Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. India Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Australia Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. China Taiwan Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Indonesia Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Thailand Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Malaysia Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Hemostatic Forceps Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Hemostatic Forceps by Type (2016-2021)
Figure 47. Sales Market Share of Hemostatic Forceps by Application (2016-2021)
Figure 48. Sales Market Share of Hemostatic Forceps by Application in 2020
Figure 49. Revenue Share of Hemostatic Forceps by Application (2016-2021)
Figure 50. Revenue Share of Hemostatic Forceps by Application in 2020
Figure 51. Manufacturing Cost Structure of Hemostatic Forceps
Figure 52. Manufacturing Process Analysis of Hemostatic Forceps
Figure 53. Hemostatic Forceps Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’